8 studies evaluated the association between CDH1 promoter methylation and ovarian cancer risk, 4 studies evaluated the relationship between CDH1 and tumor histology, and 3 studies assessed the relationship between CDH1 and tumor stage. Here, CDH1 is linked to neoplasm.